NCT00228397
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
Not specified
Clinical trial condition
Multiple Sclerosis, Relapsing-Remitting
Explore clinical trials studying Multiple Sclerosis, Relapsing-Remitting. Study availability and eligibility vary by location and protocol.
169 public trials
17 recruiting studies
Multiple Sclerosis, Relapsing-Remitting trial results
NCT00675883
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- University Hospital, London Health Sciences Centre London, Ontario, Canada
NCT00461396
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- Many Locations, Alabama, United States
- Many Locations, Arizona, United States
- Many Locations, Delaware, United States
- Many Locations, District of Columbia, United States
Completed
Real-World Betaseron Health Economic Outcomes Study for Relapsing Forms of Multiple Sclerosis
NCT01158183
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- Many Locations, Alabama, United States
- Many Locations, California, United States
- Many Locations, Colorado, United States
- Many Locations, Florida, United States
Completed
Safety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple Sclerosis
NCT00030966
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- University of Alabama-Birmingham, Department of Neurology Birmingham, Alabama, United States
- Phoenix Neurological Associates, Ltd. Phoenix, Arizona, United States
- University of Arkansas For Medical Sciences Little Rock, Arkansas, United States
- University of California - Irvine Irvine, California, United States
NCT00097760
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
Not specified
NCT00099502
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- Birmingham, Alabama, United States
- Cullman, Alabama, United States
- Phoenix, Arizona, United States
- Tucson, Arizona, United States
Completed
AVONEX® Combination Trial - "ACT"
NCT00112034
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- MS Academic Coordinating Center Cleveland, Ohio, United States
NCT00067327
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States